Profile data is unavailable for this security.
About the company
Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company operates through two segments: VITAS and the Roto-Rooter. VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Roto-Rooter provides plumbing, drain cleaning and water restoration services to both residential and commercial customers. Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. Its Water Restoration Services involve the remediation of water and humidity after a flood.
- Revenue in USD (TTM)2.38bn
- Net income in USD301.73m
- Incorporated1970
- Employees15.09k
- LocationChemed Corp255 E. Fifth Street,, Suite 2600,CINCINNATI 45202United StatesUSA
- Phone+1 (513) 762-6690
- Fax+1 (302) 636-5454
- Websitehttps://www.chemed.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hims & Hers Health Inc | 1.24bn | 101.26m | 4.76bn | 1.05k | 50.37 | 10.79 | 41.41 | 3.83 | 0.4326 | 0.4326 | 5.45 | 2.02 | 2.44 | 6.59 | 282.18 | 1,187,375.00 | 19.93 | -- | 25.93 | -- | 81.13 | -- | 8.15 | -- | 1.82 | -- | 0.00 | -- | 65.49 | -- | 64.15 | -- | -- | -- |
| Select Medical Holdings Corp | 6.97bn | 265.80m | 4.91bn | 38.40k | 17.83 | 2.58 | 8.67 | 0.7051 | 2.14 | 2.14 | 56.10 | 14.78 | 0.8885 | -- | 6.95 | 181,472.60 | 4.52 | 4.19 | 5.63 | 5.46 | 14.42 | 13.98 | 5.09 | 5.11 | -- | 4.53 | 0.5784 | 15.30 | 5.22 | 5.57 | 53.03 | 11.98 | 6.50 | -- |
| Radnet Inc | 1.77bn | -4.41m | 6.08bn | 7.87k | -- | 6.79 | 36.80 | 3.43 | -0.0654 | -0.0654 | 24.81 | 12.10 | 0.5946 | -- | 8.41 | 225,221.80 | 1.03 | 1.24 | 1.31 | 1.66 | 23.38 | 21.56 | 1.73 | 1.86 | -- | 1.38 | 0.4766 | 0.00 | 13.05 | 10.64 | -71.42 | -37.63 | 19.60 | -- |
| CorVel Corp | 845.64m | 81.52m | 6.08bn | 4.87k | 75.51 | 21.53 | 55.62 | 7.19 | 4.70 | 4.70 | 48.80 | 16.50 | 1.78 | -- | 8.93 | 173,642.30 | 17.11 | 14.87 | 29.47 | 24.21 | 21.81 | 22.14 | 9.64 | 9.16 | -- | -- | 0.00 | 0.00 | 10.68 | 5.95 | 14.90 | 10.57 | 13.87 | -- |
| Chemed Corp | 2.38bn | 301.73m | 8.28bn | 15.09k | 27.95 | 6.68 | 22.73 | 3.48 | 19.78 | 19.78 | 155.82 | 82.78 | 1.43 | 136.49 | 13.04 | 157,566.50 | 18.11 | 19.53 | 21.79 | 24.64 | 35.66 | 34.60 | 12.69 | 12.60 | 1.81 | -- | 0.00 | 8.15 | 6.06 | 4.90 | 9.17 | 5.80 | 1.46 | 6.10 |
| Ensign Group Inc | 4.11bn | 239.98m | 8.29bn | 35.30k | 35.01 | 4.74 | 25.79 | 2.02 | 4.13 | 4.13 | 70.86 | 30.50 | 0.9433 | -- | 8.01 | 116,391.30 | 5.52 | 6.45 | 6.63 | 7.88 | 21.19 | 22.32 | 5.85 | 6.48 | -- | -- | 0.0773 | 6.56 | 23.27 | 16.28 | -6.80 | 28.62 | 4.40 | 5.02 |
| Encompass Health Corp | 5.22bn | 431.20m | 9.97bn | 22.36k | 23.41 | 5.09 | 11.66 | 1.91 | 4.23 | 4.11 | 51.10 | 19.45 | 0.8396 | -- | 9.38 | 233,270.70 | 9.07 | 6.37 | 11.87 | 7.94 | 95.49 | 95.58 | 10.80 | 9.16 | -- | 6.14 | 0.486 | 30.78 | 10.41 | 2.34 | 41.31 | 4.49 | 16.60 | -10.42 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Sep 2024 | 1.64m | 10.93% |
| BlackRock Fund Advisorsas of 30 Sep 2024 | 1.24m | 8.25% |
| Kayne Anderson Rudnick Investment Management LLCas of 30 Sep 2024 | 592.95k | 3.94% |
| Neuberger Berman Investment Advisers LLCas of 30 Sep 2024 | 495.75k | 3.29% |
| William Blair Investment Management LLCas of 30 Sep 2024 | 488.25k | 3.24% |
| SSgA Funds Management, Inc.as of 30 Sep 2024 | 464.35k | 3.09% |
| Geode Capital Management LLCas of 30 Sep 2024 | 335.44k | 2.23% |
| Impax Asset Management Ltd.as of 30 Sep 2024 | 332.76k | 2.21% |
| TD Asset Management, Inc.as of 30 Sep 2024 | 292.66k | 1.95% |
| Epoch Investment Partners, Inc.as of 30 Sep 2024 | 240.07k | 1.60% |
